Drug-Coated Stents Face Further Scrutiny

Law360, New York (November 30, 2006, 12:00 AM EST) -- With a Food and Drug Administration advisory panel set to examine drug-coated stents at an upcoming meeting, a report has shown that the devices increase the risk of life-threatening blood clots in patients with coronary artery disease by four or five times that of bare-metal stents.

The analysis, which was released Wednesday by the Cleveland Clinic, added to the growing body of evidence that drug-coated stents potentially trigger more heart attacks than their older and cheaper bare-metal counterparts.

“Our analysis found there is a small, but...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.